Brief: Vectivbio To Acquire Comet Therapeutics And Host Research And Development Day
31/08/2021 12:33
Aug 31 (Reuters) - VectivBio Holding AG VECT.O :
* VECTIVBIO TO ACQUIRE COMET THERAPEUTICS AND HOST RESEARCH
AND
DEVELOPMENT DAY
* VECTIVBIO HOLDING AG - WILL ACQUIRE COMET THERAPEUTICS INC
* VECTIVBIO HOLDING AG - WILL ACQUIRE COMET THERAPEUTICS IN
EXCHANGE FOR EQUITY AND CASH PAYABLE AT CLOSING
* VECTIVBIO HOLDING AG - DEAL INCLUDES ADDITIONAL EQUITY OR
CASH
PAYMENTS UPON ACHIEVEMENT OF CERTAIN SPECIFIED FUTURE
DEVELOPMENT MILESTONES
Source text for Eikon: ID:nGNX5ZPrkd
Further company coverage: VECT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VectivBio Holding AG
See all newsBrief: Ironwood And VectivBio Announce Expiration Of Hart-Scott-Rodino Waiting Period For Proposed Acquisition Of VectivBio
Brief: Ironwood Pharmaceuticals Says If Deal Aborts, VectivBio To Pay Termination Fee
U.S. STOCKS ON THE MOVE-Pfizer, Zoom Video, American Airlines
U.S. STOCKS ON THE MOVE-Atea Pharma, Microbot Medical, Krystal
U.S. STOCKS ON THE MOVE-NuScale Power Corp, Foot Locker, Greenhill